Blood and tissue tests to find markers in muscle and skin disease
Part of Bones, joints & muscles, Brain & nervous system, Skin clinical trials.
This study looks for blood and tissue “biomarkers” (measurable clues in samples) to help diagnose and predict outcomes in inflammatory muscle diseases and systemic sclerosis (a skin/organ condition). If you’re being evaluated for myopathy or early scleroderma, it may help doctors sort out the cause and follow your health more closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can participate regardless of sex
- You fit one of these groups: suspected or confirmed inflammatory myopathy, primary Raynaud’s with no systemic sclerosis, or early diffuse systemic cutaneous scleroderma
- Your doctor can safely do the needed biopsy (muscle for myopathy; skin for scleroderma groups)
- You have not been on certain immune-suppressing medicines recently (within the last 3 months, or longer for some scleroderma-related medicines)
- You do not have an important heart problem that is not well controlled
- If you are pregnant or breastfeeding, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study looks at a specific type of immune cell activity (called neutrophil extracellular traps) in the blood of people with systemic sclerosis, other connective tissue diseases, and healthy volunteers. It aims to understand how these cells may be involved in the disease and could lead to better treatments.
This study follows adults with systemic sclerosis who are being seen at a specific hospital and asks for consent to store blood and other samples for future research. It may help researchers better understand the disease and develop better tests or treatments over time.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This trial collects clinical and lab information (like blood and medical history) from people with rare autoimmune diseases, especially when symptoms are unusual. It aims to better understand what causes these illnesses and how newer treatments may help.
This study uses skin samples from people with scleroderma, their relatives, and healthy volunteers to create stem cells in a lab. The goal is to learn more about the disease and find better ways to treat it.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.